Israeli Treatment for Severe Cases of COVID-19 Shows Excellent Results in Phase 2 Trials

By Benjamin Kerstein, Algemeiner— An Israeli treatment for patients suffering from severe cases of Covid-19 showed excellent results in its Phase 2 trials. Israeli news site N12 reported that Israeli company Enlivex Therapeutics announced the results of the trials of its drug Allocetra on Wednesday. Allocetra is intended to prevent the immune system from overreacting…